Cargando…
BMPR2 mutations and response to inhaled or parenteral prostanoids: a case series
Whether mutations in the BMPR2 gene may influence the response to PAH-specific therapies has not yet been investigated. In this study, in 13 idiopathic, heritable or anorexigen-associated PAH patients, in whom treatment escalation was performed by adding a prostanoid, a greater haemodynamic improvem...
Autores principales: | Scelsi, Laura, Greco, Alessandra, Acquaro, Mauro, Olivieri, Carla, Sobrero, Matteo, Turco, Annalisa, Cappelletti, Donata, Visconti, Luigi Oltrona, Ghio, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652182/ https://www.ncbi.nlm.nih.gov/pubmed/34900222 http://dx.doi.org/10.1177/20458940211037275 |
Ejemplares similares
-
Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2
por: Greco, Alessandra, et al.
Publicado: (2018) -
Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial Hypertension
por: Scelsi, Laura, et al.
Publicado: (2020) -
When you hear hoofbeats, think zebras – pulmonary veno‐occlusive disease: A case report
por: Scelsi, Laura, et al.
Publicado: (2022) -
Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy
por: Ghio, Stefano, et al.
Publicado: (2016) -
Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy
por: Fronza, Matteo, et al.
Publicado: (2016)